125 related articles for article (PubMed ID: 26010984)
41. Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
Veneri D; Ambrosetti A; Franchini M; Mosna F; Poli G; Pizzolo G
Haematologica; 2005 Nov; 90 Suppl():ECR37. PubMed ID: 16266928
[TBL] [Abstract][Full Text] [Related]
42. T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
Dincol G; Agan M; Dogan O; Diz-Kucukkaya R; Uslu B
Clin Lab Haematol; 2006 Dec; 28(6):419-22. PubMed ID: 17105497
[TBL] [Abstract][Full Text] [Related]
43. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
44. [Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].
Mounedji-Boudiaf L; Culine S; Devoldère G; Terrier-Lacombe MJ; Kattan J; Cazier A; Farhat F; Bekradda M; Droz JP
Bull Cancer; 1994 Apr; 81(4):334-7. PubMed ID: 7703552
[TBL] [Abstract][Full Text] [Related]
45. The best treatment for diffuse large B-cell lymphoma: a German perspective.
Schmits R; Schmitz N; Pfreundschuh M;
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):16-25. PubMed ID: 15934514
[TBL] [Abstract][Full Text] [Related]
46. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
[TBL] [Abstract][Full Text] [Related]
47. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Récher C; Coiffier B; Haioun C; Molina TJ; Fermé C; Casasnovas O; Thiéblemont C; Bosly A; Laurent G; Morschhauser F; Ghesquières H; Jardin F; Bologna S; Fruchart C; Corront B; Gabarre J; Bonnet C; Janvier M; Canioni D; Jais JP; Salles G; Tilly H;
Lancet; 2011 Nov; 378(9806):1858-67. PubMed ID: 22118442
[TBL] [Abstract][Full Text] [Related]
48. [Intravascular lymphomatosis: a case report].
Adachi H; Tsuboi M; Hayashi K
No Shinkei Geka; 2001 Jul; 29(7):659-65. PubMed ID: 11517508
[TBL] [Abstract][Full Text] [Related]
49. Clinical and histological resolution of a basal cell carcinoma in a patient undergoing concurrent treatment of B-cell lymphoma with systemic R-CHOP.
Rahman SM; Bhat W; Wiper JD; Platt AJ
J Plast Reconstr Aesthet Surg; 2014 Sep; 67(9):e223-5. PubMed ID: 25052183
[TBL] [Abstract][Full Text] [Related]
50. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
51. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
Sehn LH; Connors JM
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):26-34. PubMed ID: 15934515
[TBL] [Abstract][Full Text] [Related]
52. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
53. Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Schmitz N; Nickelsen M; Ziepert M; Haenel M; Borchmann P; Schmidt C; Viardot A; Bentz M; Peter N; Ehninger G; Doelken G; Ruebe C; Truemper L; Rosenwald A; Pfreundschuh M; Loeffler M; Glass B;
Lancet Oncol; 2012 Dec; 13(12):1250-9. PubMed ID: 23168367
[TBL] [Abstract][Full Text] [Related]
54. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis.
Patiar S; Ramsden JD; Freeland AP
J Laryngol Otol; 2005 Aug; 119(8):646-8. PubMed ID: 16102224
[TBL] [Abstract][Full Text] [Related]
55. Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial.
Watanabe T; Tobinai K; Shibata T; Tsukasaki K; Morishima Y; Maseki N; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Takeuchi K; Nawano S; Terauchi T; Hotta T
J Clin Oncol; 2011 Oct; 29(30):3990-8. PubMed ID: 21931035
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
[TBL] [Abstract][Full Text] [Related]
57. Primary pancreatic lymphoma presenting as recurrent idiopathic pancreatitis: a diagnostic dilemma.
Mimery A; De Clercq S
ANZ J Surg; 2020 Apr; 90(4):E81-E82. PubMed ID: 31218769
[No Abstract] [Full Text] [Related]
58. Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease.
Borges E; Ferry JA; Friedmann AM
Transplantation; 2002 Feb; 73(4):541-3. PubMed ID: 11889425
[TBL] [Abstract][Full Text] [Related]
59. Coexistent B-cell lymphoma and cutaneous T-cell lymphoma.
Inokuchi T; Shincho M; Moriwaki Y; Ka T; Takahashi S; Tsutsumi Z; Lin Y; Hirota S; Yamamoto T
Intern Med; 2006; 45(9):641-7. PubMed ID: 16755097
[TBL] [Abstract][Full Text] [Related]
60. Soft Palate Ulcer: An Unusual Presentation of a Posttransplant Lymphoproliferative Disorder.
Bahmanyar M; Shakibazad N; Imanieh MH; Dehghani SM
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e97-e99. PubMed ID: 27918349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
